SEARCH

SEARCH BY CITATION

References

  • 1
    Jonathan S, Tam NV, Hampson AW. The epidemiology and impact of pandemic influenza. Vaccine 2003; 21:17621768.
  • 2
    Ito T, Kawaoka Y. Avian influenza; in Nicholson KG, Webster RG, Hay AJ (ed.): Textbook of Influenza. London: Blackwell Scientific Publications, 1998; 126136.
  • 3
    Dowdle WR. Influenza A virus recycling revisited. Bull World Health Organ 1999; 77:820828.
  • 4
    Taubenberger JK, Reid AH, Krafft AE, Bijwaard KE, Fanning TG. Initial genetic characterization of the 1918 “Spanish” influenza virus. Science 1997; 275:17931796.
  • 5
    Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M. Transmission of influenza A in human beings. Lancet Infect Dis 2007; 7:257265.
  • 6
    Aoki FY, Boivin G. Influenza virus shedding – excretion patterns and effects of antiviral treatment. J Clin Virol 2009; 44:255261.
  • 7
    Centers for Disease Control and Prevention (CDC). Influenza symptoms. Available at http://www.cdc.gov/Flu/symtoms.htm (Accessed 13 October 2009).
  • 8
    Centers for Disease Control and Prevention (CDC). Interim guidance for clinicians on identifying and caring for patients with swine-origin influenza A (H1N1) virus infection. Available at http://www.cdc.gov/h1n1flu/identifyingpatients.htm (Accessed 4 May 2009).
  • 9
    Odaira F, Takahasshi H, Toyokawa T et al. Assessment of secondary attack rate and effectiveness of antiviral prophylaxis among household contacts in an influenza A(H1N1)v outbreak in Kobe, Japan, May–June 2009. Euro Surveill 2009; 14:19320.
  • 10
    World Health Organization (WHO). New influenza A (H1N1) virus: global epidemiological situation, June 2009. Wkly Epidemiol Rec 2009; 84:249257. Available at http://www.who.int/wer/2009/wer8425/en/index.html.
  • 11
    WHO/SEARO. Pandemic (H1N1) (2009). Priority areas for research. Available at http://www.searo.who.int/.../CDS_H1N1_2009_Research_priorities.pdf.
  • 12
    World Health Organization (WHO). Clinical management of pandemic (H1N1) 2009 virus infection. EMRO Interim Guidance from Expert Consultation, 17 September 2009; 13.
  • 13
    Viboud C, Boelle PY, Cauchemez S et al. Risk factors of influenza transmission in households. Br J Gen Pract 2004; 45:684689.
  • 14
    Chowell G, Miller MA, Viboid C. Seasonal influenza in the United States, France and Australia: transmission and prospects for control. Epidemiol Infect 2008; 136:852864.
  • 15
    Yang Y, Sugimoto JD, Halloran ME et al. The transmissibility and control of pandemic influenza A(H1N1) virus. Science 2009; 326:729733.
  • 16
    Fraser C. Estimating individual and household reproduction number in an emerging epidemic. PLoS ONE 2007; 2:e758.
  • 17
    Boven MV, Donker T, Lubben MV et al. Transmission of novel influenza A(H1N1) in households with post exposure antiviral prophylaxis. PLoS ONE 2010; 5:e11442.
  • 18
    Anderson RM, May RM. Infectious Diseases of Humans. New York: Oxford University Press, 1991.
  • 19
    Ghani AC, Baguelin M, Griffin J et al. The early transmission dynamics of H1N1 pdm influenza in the United Kingdom. Plos Curr 2009; 1:RRN1130.
  • 20
    Odaira F, Takahashi H, Toyokawa T et al. Assessment of secondary attack rate and effectiveness of antiviral prophylaxis among household contacts in an influenza A (N1H1) outbreak in Kobe, Japan, May–June 2009. Euro Surveill 2009; 14:pii 19320.
  • 21
    Cauchemez S, Donnelly CA, Reed C et al. Household transmission of 2009 pandemic influenza A(N1H1) virus in United States. N Engl J Med 2009; 361:26192627.
  • 22
    Monto AS. Interrupting the transmission of respiratory tract infections: theory and practice. Clin Infect Dis 1999; 28:200204.
  • 23
    Reichert T, Chowell G, Hiroshi Nishiura H, Christensen RA, McCullers JA. Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza? BMC Infect Dis 2010; 10:5. doi: 10.1186/1471-2334-10-5.
  • 24
    Welliver R, Monto AS, Carewicz O et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA 2001; 285:748754.
  • 25
    Hayden FG, Gubareva LV, Monto AS et al. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. N Engl J Med 2000; 343:12821289.
  • 26
    Gubareva LV, Novikov DV, Hayden FG. Assessment of hemagglutinin sequence heterogeneity during influenza virus transmission in families. J Infect Dis 2002; 186:15751581.